Icon

OJJAARA (NDA216873)- (EQ 100MG BASE,EQ 150MG BASE,EQ 200MG BASE)

MOMELOTINIB DIHYDROCHLORIDE GLAXOSMITHKLINE
EQ 100MG BASE,EQ 150MG BASE,EQ 200MG BASE
No No
2040-Dec-02 2028-Sep-15
None None
None No
OJJAARA is a kinase inhibitor indicated for the treatment of intermediate or high-risk myelofibrosis (MF), including primary MF or secondary MF [post-polycythemia vera (PV) and post-essential thrombocythemia (ET)], in adults with anemia.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 100MG BASE ** ** - - -
EQ 150MG BASE ** ** - - -
EQ 200MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.